CIK: 1216855 - Address: 10165 McKellar Court, San Diego, CA 92121
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret112588-2183211
P%wins100100505010010083

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/5/11 21:55
1/3/11
QDELQuidel Corp /de/DEHealthDiagnIn Vitro & In Vivo DiagnosticRadak John MatthewCAOCFOM.d00.0020121D134173212421-8-3-7-17106
6/22/10 20:22
5/21/10
QDELQuidel Corp /de/DEHealthDiagnIn Vitro & In Vivo DiagnosticRadak John MatthewCAOCFOP.a1111.4751521D-32-13-7-5-41115006-1-41421
6/14/10 20:50
6/10/10
QDELQuidel Corp /de/DEHealthDiagnIn Vitro & In Vivo DiagnosticRadak John MatthewCAOCFOP1110.6161522D-35-22-16-21-26-6-529101612143
3/1/07 16:55
2/28/07
IVGNInvitrogen CorpDEHealthBioPrdBiological Products, (No DiagRadak John MatthewCAOVP FinanM.d2329.7001732D
3/1/07 16:55
2/28/07
IVGNInvitrogen CorpDEHealthBioPrdBiological Products, (No DiagRadak John MatthewCAOVP FinanS.d-4964.280-1-302D
5/17/06 20:23
5/15/06
IVGNInvitrogen CorpDEHealthBioPrdBiological Products, (No DiagRadak John MatthewCAOVP FinanS.d-2667.0500-182
8/8/05 19:35
8/5/05
IVGNInvitrogen CorpDEHealthBioPrdBiological Products, (No DiagRadak John MatthewCAOVP,FinanS.d-2285.4300-1000D
2/24/05 18:53
2/22/05
IVGNInvitrogen CorpDEHealthBioPrdBiological Products, (No DiagRadak John MatthewCAOVP FinanS-9169.640-1-1000D
8/29/03 12:11
8/29/03
IVGNInvitrogen CorpDEHealthBioPrdBiological Products, (No DiagRadak John MatthewCAOVP FinaS-3657.950-1-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact